The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Open accessAbstract
OBJECTIVE—Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either retrospective chart reviews or clinical trials not rigorously controlled for concomitant glucose- and lipid-lowering therapies. This study examines the lipid and glycemic effects of pioglitazone and rosiglitazone. RESEARCH DESIGN AND METHODS—We enrolled subjects with a diagnosis of type 2 diabetes (treated with diet alone or oral monotherapy) and dyslipidemia (not treated with any lipid-lowering agents). After a 4-week placebo washout period, subjects randomly assigned to the pioglitazone arm (n = 400) were treated with 30 mg once daily for 12 weeks followed by 45 mg once daily for an additional 12 weeks, whereas subjects randomly assigned to rosiglitazone (n = 402) were treated with 4 mg once daily followed by 4 mg twice daily for the same intervals. RESULTS—Triglyceride levels were reduced by 51.9 ± 7.8 mg/dl with pioglitazone, but were increased by 13.1 ± 7.8 mg/dl with rosiglitazone (P < 0.001 between treatments). Additionally, the increase in HDL cholesterol was greater (5.2 ± 0.5 vs. 2.4 ± 0.5 mg/dl; P < 0.001) and the increase in LDL cholesterol was less (12.3 ± 1.6 vs. 21.3 ± 1.6 mg/dl; P < 0.001) for pioglitazone compared with rosiglitazone, respectively. LDL particle concentration was reduced with pioglitazone and increased with rosiglitazone (P < 0.001). LDL particle size increased more with pioglitazone (P = 0.005). CONCLUSIONS—Pioglitazone and rosiglitazone have significantly different effects on plasma lipids independent of glycemic control or concomitant lipid-lowering or other antihyperglycemic therapy. Pioglitazone compared with rosiglitazone is associated with significant improvements in triglycerides, HDL cholesterol, LDL particle concentration, and LDL particle size.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Clinical Epidemiology: The Essentials.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-825_10 · Cited by 1,835
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Lipids and Lipoproteins in Patients With Type 2 Diabetes
Krauss, R. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1496 · Cited by 756
Reaven, G. M., Chen, Y. D., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 690
Aronoff, S., Rosenblatt, S., Braithwaite, S., Egan, J. W., Mathisen, A. L., & Schneider, R. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1605 · Cited by 629
Garvey, W. T., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A., Pugh, K., Jenkins, A. J., Klein, R. L., & Liao, Y. (2003) · Diabetes · doi:10.2337/diabetes.52.2.453 · Cited by 607
Linear Models for Unbalanced Data
Turner, D. (1989) · Technometrics · doi:10.1080/00401706.1989.10488483 · Cited by 582
Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes
Lebovitz, H. E., Dole, J., Patwardhan, R., Rappaport, E. B., & Freed, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.280 · Cited by 518
Dyslipidemia Management in Adults With Diabetes
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s68 · Cited by 445
Lamarche, B. (1998) · JAMA · doi:10.1001/jama.279.24.1955 · Cited by 417
Phillips, L. S., Grunberger, G., Miller, E., Patwardhan, R., Rappaport, E. B., Salzman, A., & the Rosiglitazone Clinical Trials Study Group (2001) · Diabetes Care · doi:10.2337/diacare.24.2.308 · Cited by 302
Haffner, S. M., D'Agostino, R., Mykkänen, L., Tracy, R., Howard, B., Rewers, M., Selby, J., Savage, P. J., & Saad, M. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.562 · Cited by 297
A Meta-analysis Comparing the Effect of Thiazolidinediones on Cardiovascular Risk Factors
Chiquette, E., Ramirez, G., & DeFronzo, R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2097 · Cited by 291
Epidemiology in public health practice
(2010) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-140-8 · Cited by 285
Khan, M. A., St. Peter, J. V., & Xue, J. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.708 · Cited by 250
Self-citationFreed, M. I., Ratner, R., Marcovina, S. M., Kreider, M. M., Biswas, N., Cohen, B. R., & Brunzell, J. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02659-0 · Cited by 238
The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive)
Charbonnel, B., Dormandy, J., Erdmann, E., Massi-Benedetti, M., Skene, A., & PROactive Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1647 · Cited by 231
Correlation between cardiovascular disease and diabetes mellitus: current concepts
Nesto, R. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.016 · Cited by 231
Insulin resistance and the endothelium
Hsueh, W. A., Lyon, C. J., & Quiñones, M. J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.042 · Cited by 229
Rosenblatt, S., Miskin, B., Glazer, N. B., Prince, M. J., & Robertson, K. E. (2001) · Coronary Artery Disease · doi:10.1097/00019501-200108000-00011 · Cited by 221
Raskin, P., Rappaport, E. B., Cole, S. T., Yan, Y., Patwardhan, R., & Freed, M. I. (2000) · Diabetologia · doi:10.1007/s001250050045 · Cited by 216
Taskinen, M.-R. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)00006-x · Cited by 214
Calcium and Vitamin D Intake and Risk of Incident Premenstrual Syndrome
Bertone-Johnson, E. R., Hankinson, S. E., Bendich, A., Johnson, S. R., Willett, W. C., & Manson, J. E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.11.1246 · Cited by 205
Becoming a medical information master: feeling good about not knowing everything.
Slawson, D. C., Shaughnessy, A. F., & Bennett, J. H. (1994) · PubMed · Cited by 183
Patel, J., Anderson, R. J., & Rappaport, E. B. (1999) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.00020.x · Cited by 181
Siegel, R. D., Cupples, A., Schaefer, E. J., & Wilson, P. W. F. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90246-2 · Cited by 176
Premenstrual Dysphoric Disorder
Grady-Weliky, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp012067 · Cited by 172
Thiazolidinediones and Blood Lipids in Type 2 Diabetes
van Wijk, J. P. H., de Koning, E. J. P., Martens, E. P., & Rabelink, T. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000090521.25968.4d · Cited by 165
Boyle, P. J., King, A. B., Olansky, L., Marchetti, A., Lau, H., Magar, R., & Martin, J. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85040-8 · Cited by 161
Sobel, B. E., Frye, R. L., & Detre, K. M. (2003) · Circulation · doi:10.1161/01.cir.0000048897.03553.e4 · Cited by 144
Nutritional factors in the etiology of the premenstrual tension syndromes.
Abraham, G. E. (1983) · PubMed · Cited by 132
Buse, J. B., Tan, M. H., PRINCE, M. J., & Erickson, P. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00325.x · Cited by 132
Self-citationHerz, M., Johns, D., Reviriego, J., Grossman, L. D., Godin, C., Durán, S., Hawkins, F. G., Lochnan, H. A., Escobar‐Jiménez, F., Hardin, P. A., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80068-1 · Cited by 132
Self-citationDerosa, G., Cicero, A. F. G., Gaddi, A. V., Ragonesi, P. D., Fogari, E., Bertone, G., Ciccarelli, L., & Piccinni, M. N. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90074-4 · Cited by 128
Nolan, J. J., Jones, N. P., Patwardhan, R., & Deacon, L. F. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00269.x · Cited by 117
Obtaining useful information from expert based sources
Slawson, D. C., & Shaughnessy, A. F. (1997) · BMJ · doi:10.1136/bmj.314.7085.947 · Cited by 117
A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
King, A. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.557b · Cited by 111
Lahdenper, S., Syv�nne, M., Kahri, J., & Taskinen, M. (1996) · Diabetologia · doi:10.1007/bf00400677 · Cited by 110
Gaudiani, L., Lewin, A., Meneghini, L., Perevozskaya, I. T., Plotkin, D. J., Mitchel, Y., & Shah, S. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00420.x · Cited by 75
When less is more: a practical approach to searching for evidence-based answers.
Grandage, K. K., Slawson, D. C., & Shaughnessy, A. F. (2002) · Europe PMC (PubMed Central) · Cited by 69
Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy
Ginsberg, H. N. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01489-8 · Cited by 61
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000139012.45265.e0 · Cited by 54
Aronoff, S. L., Rosenblatt, S., Braithwaite, S. S., et al. (2000) · Cited by 48
Peters, A. L., Kendall, D. M., Buse, J. B., Boyle, P. J., Marchetti, A. E., & Lau, H. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125002937 · Cited by 46
Self-citationOlansky, L., Marchetti, A. E., & Lau, H. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80243-6 · Cited by 45
Differences in Lipid Profiles of Patients Given Rosiglitazone Followed by Pioglitazone
LaCivita, K. A., & Villarreal, G. E. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125001038 · Cited by 43
Lewin, A. J., Kipnes, M. S., Meneghini, L., Plotkin, D. J., Perevozskaya, I. T., Shah, S., Maccubbin, D., Mitchel, Y., & Tobert, J. A. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90033-1 · Cited by 38
Dell, D. L. (2004) · Clinical Obstetrics & Gynecology · doi:10.1097/01.grf.0000135298.39050.b3 · Cited by 35
A Case of Lipoatrophy With Insulin Glargine
Ampudia‐Blasco, F. J., Girbés, J., & Carmena, R. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2983 · Cited by 28
Gegick, C. G., & Altheimer, M. D. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003908 · Cited by 23
ZARICH, S. W. (2003) · PubMed · Cited by 15
Dyslipidemia in Type 2 Diabetes and the Effects of Thiazolidinediones
Bell, D. S. H. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000098612.88907.4b · Cited by 7
Cited by
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Self-citationNathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Self-citationRinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
PPARγ signaling and metabolism: the good, the bad and the future
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016
Metadata
- Authors
- Goldberg, R. B., Kendall, D. M., Deeg, M. A., Buse, J. B., Zagar, A. J., Pinaire, J. A., Tan, M. H., Khan, M. A., Perez, A. T., Jacober, S. J., & for the GLAI Study Investigators
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2005-07-01
- Volume
- 28
- Issue
- 7
- Pages
- 1547-1554
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2102675827
- Cited by
- 795
- References
- 63
- FWCI
- 55.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.